MCF Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

MCF Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$906K	Sell	16,985 -183	-1%	-$10.7K	0.04%	185
2025 Q4	$1.07M	Buy	17,168 +16,907	+6,478%	+$1.04M	0.06%	128
2025 Q3	$15.7K	Hold	261	–	–	﹤0.01%	623
2025 Q2	$16.4K	Hold	261	–	–	﹤0.01%	584
2025 Q1	$15.7K	Hold	261	–	–	﹤0.01%	583
2024 Q4	$15.2K	Hold	261	–	–	﹤0.01%	599
2024 Q3	$15.5K	Hold	261	–	–	﹤0.01%	594
2024 Q2	$14.6K	Buy	+261	New	+$14.6K	﹤0.01%	592
2020 Q3	–	Sell	-156	Closed	-$7K	–	484
2020 Q2	$7K	Hold	156	–	–	﹤0.01%	395
2020 Q1	$6K	Buy	+156	New	+$6.57K	﹤0.01%	398

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MCF Advisors's IHI Position: Q1 2026 in Review

MCF Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 1.1% in Q1 2026, selling an estimated $10.7K and leaving 16,985 shares worth $906K. The position accounts for 0.04% of the portfolio, ranked #185.

MCF Advisors first reported a position in IHI in Q1 2020 and has held it in 10 quarters since. The position peaked at $1.07M in Q4 2025. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

MCF Advisors held 16,985 shares of iShares US Medical Devices ETF worth $906K as of Q1 2026.
MCF Advisors sold 183 iShares US Medical Devices ETF shares in Q1 2026, an estimated $10.7K.
iShares US Medical Devices ETF made up 0.04% of MCF Advisors's portfolio in Q1 2026, its #185 holding.
MCF Advisors first reported a position in iShares US Medical Devices ETF in Q1 2020 and has held it in 10 quarters since.
MCF Advisors's iShares US Medical Devices ETF position peaked at $1.07M in Q4 2025.
503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.